ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 19 of 45
Up
УЖМБС 2021, 6(6): 152–157
https://doi.org/10.26693/jmbs06.06.152
Clinical Medicine

Hemorrhagic Encephalitis after COVID-19 (Clinical Case)

Filiuk I. O. 1,2, Kalbus O. I. 1,2, Shastun N. P. 1,2, Andreichenko D. I. 2
Abstract

COVID-19 is an urgent problem all over the world that affects not only the respiratory system, but also causes many neurological disorders. In connection with the clinical manifestations of COVID-19, further detailed study of neurological complications is required, such as ischemic and hemorrhagic strokes, damage to the peripheral nervous system, and inflammatory diseases of the brain. Some neurological symptoms after an illness may persist for several weeks or even months. Hemorrhagic encephalitis is one such complication of COVID-19. Taking into account the growth of COVID-19 and frequent neurological complications after a previous illness, more and more often patients will seek medical help from a specialist, such as a neurologist, psychologist, psychiatrist. The only protection against COVID-19, which causes serious complications, is vaccination. The purpose of the study was to highlight a rare case of hemorrhagic encephalitis, which developed against the background of the previous COVID-19 disease. Materials and methods. The work is based on a description of a clinical case of hemorrhagic encephalitis in a patient who has undergone COVID-19. The modern literature data on the clinical and diagnostic features and therapeutic possibilities of hemorrhagic encephalitis are presented. Results and discussion. The article examines data on the clinical manifestations of COVID-19, which can occur in both mild and severe forms, reflects the diagnostic criteria of this disease, highlights treatment approaches, discusses in detail and provides data on the main aspects of the pathogenetic mechanisms underlying development of the disease. Complications of COVID-19 have been described, not only from the central and peripheral nervous system, but also from other systems. The second part of the article is presented in the form of a clinical case of hemorrhagic encephalitis against the background of the undergone COVID-19, which was recorded in our hospital. This part of the article describes in detail the patient's complaints and anamnestic data, the data of the somatic and neurological examination at the time of admission to the hospital and in dynamics, and describes the treatment tactics. Attention is especially focused on the cognitive functions of this patient, which will become the reason for seeing a psychiatrist in the future. Conclusion. Neurological complications of COVID-19 are increasingly registered, requiring close attention from neurologists. Hemorrhagic encephalitis can be one of these complications

Keywords: COVID-19, complication, hemorrhagic encephalitis, nervous system

Full text: PDF (Ukr) 292K

References
  1. Belyakov NA, Rassokhin VV, Yastrebova EB. Coronavirus infectious disease COVID-19: nature of virus, pathogenesis, clinical manifestations, report 1. HIV Infection and Immunosuppressive Disorders. 2020;12(1):7-21. [Russian]. https://doi.org/10.22328/2077-9828-2020-12-1-7-21
  2. Carod-Artal FJ. Neurological complications of coronavirus and COVID-19. Rev Neurol. 2020;70(09):311–22. https://www.ncbi.nlm.nih.gov/pubmed/32329044. https://doi.org/10.33588/rn.7009.2020179
  3. Acharya A, Kevadiya BD, Gendelman HE, Byrareddy SN. SARS-CoV-2 infection leads to neurological dysfunction. J NeuroImmune Pharmacol. 2020;15(2):167–73. https://www.ncbi.nlm.nih.gov/pubmed/32447746. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc7244399. https://doi.org/10.1007/s11481-020-09924-9
  4. Markus HS. EXPRESS: COVID-19 and Stroke - A Global World Stroke Organisation perspective. Int J Stroke. 2020;15(4):361-364. https://www.ncbi.nlm.nih.gov/pubmed/32310017. https://doi.org/10.1177/1747493020923472
  5. Li X, Zai J, Zhao Q, Nie Q, Li Y, Foley BT, et al. Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2. J Med Virol. 2020;92(6):602-611. https://www.ncbi.nlm.nih.gov/pubmed/32104911. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc7228310. https://doi.org/10.1002/jmv.25731
  6. Price-Haywood EG, Burton J, Fort D, Seo AL. Hospitalization and mortality among black patients and white patients with Covid-19. N Engl J Med. 2020;382(26):2534-2543. https://www.ncbi.nlm.nih.gov/pubmed/32459916. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc7269015. https://doi.org/10.1056/NEJMsa2011686
  7. COVID-19 Host Genetics Initiative. The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic. Eur J Hum Genet. 2020;28(6):715-718. https://www.ncbi.nlm.nih.gov/pubmed/32404885 https://www.ncbi.nlm.nih.gov/pmc/articles/pmc7220587. https://doi.org/10.1038/s41431-020-0636-6
  8. Gates P. Clinical Neurology. A Primer. Elsevier; 2010. 425 p.
  9. Josephson S, Hauser S. Harrison's Neurology in Clinical Medicine. 4th ed. NY: McGraw-Hill Education LLC; 2017. 994 p.
  10. Guerrero J, Barragán L, Martínez J, Montoya J, Peña A, Sobrino F, et al. Central and peripheral nervous system involvement by COVID-19: a systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings. BMC Inf Dis. 2021;21(1). https://www.ncbi.nlm.nih.gov/pubmed/34078305. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc8170436. https://doi.org/10.1186/s12879-021-06185-6